10.3390/metabo13010124 94 ThilakarathnaS
In an experimental model of Alzheimers disease induced by aluminum chloride, dapagliflozin shows neuroprotective effects by suppressing brain amyloid- protein deposition
Understanding the differences can help make an informed decision
Two panelists covered recent findings related to how GLP-1 agonists produce adverse side effects such as vomiting and thirst suppression, while the other two talked about new approaches in GLP-1 therapies
Owing to intrinsic limitations of network meta-analysis, we avoided to analyze the effects of these drugs in several subgroupse.g., as stratified by age or the presence of CV disease or type 2 diabetesto avoid type 1 error due to the many subgroup analyses
Last reviewed: May 14, 2026 Last updated: May 14, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations